A Network of Genetic Events Sufficient to Convert Normal Human Cells to a Tumorigenic State
Open Access
- 1 November 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (21) , 9824-9828
- https://doi.org/10.1158/0008-5472.can-05-1543
Abstract
Although great progress has been made at identifying and characterizing individual genes involved in cancer, less is known about how the combination of such genes collaborate to form tumors in humans. To this end, we sought to genetically recreate tumorigenesis in normal human cells using genes altered in human cancer. We now show that expression of mammalian proteins that inactivate the tumor suppressors Rb and p53 in conjunction with the oncoproteins Ras and Myc and the telomerase subunit hTERT is sufficient to drive a number of normal human somatic cells to a tumorigenic fate. This provides a blueprint of the events that lead to human cancer, allowing different cancers to be genetically modeled from normal human cells.Keywords
This publication has 18 references indexed in Scilit:
- Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56γ KnockdownCancer Research, 2004
- Species- and cell type-specific requirements for cellular transformationCancer Cell, 2004
- Cellular Targets of the SV40 Small-t Antigen in Human Cell TransformationCell Cycle, 2004
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- SV40 and human tumours: myth, association or causality?Nature Reviews Cancer, 2002
- Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell TransformationMolecular and Cellular Biology, 2002
- The Hallmarks of CancerCell, 2000
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomeraseOncogene, 1998